These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16557168)

  • 1. [Cytotoxicity evaluation of different eyes drops with cyclosporine oral solution (Sandimmun)].
    Nourry H; Perrot S; Martin C; Chaumeil C; Cambourieu C; Rat P; Warnet JM
    J Fr Ophtalmol; 2006 Mar; 29(3):251-7. PubMed ID: 16557168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cyclosporine 2% eye drops preparation].
    Chast F; Lemare F; Legeais JM; Batista R; Bardin C; Renard G
    J Fr Ophtalmol; 2004 Jun; 27(6 Pt 1):567-76. PubMed ID: 15343115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of topical cyclosporine A and dissolvent on corneal epithelium permeability of fluorescein.
    Benítez del Castillo JM; Castillo A; Toledano N; Durán S; del Aguila C; Otero M; García-Sanchez J
    Doc Ophthalmol; 1995; 91(1):49-55. PubMed ID: 8861636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicological evaluation of cyclosporine eyedrops.
    Knagenhjelm SK; Frøyland K; Ringvold A; Bjerkås E; Kjønniksen I
    Acta Ophthalmol Scand; 1999 Apr; 77(2):200-3. PubMed ID: 10321539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular irritation and cyclosporine A distribution in the eye tissues after administration of Solid Lipid Microparticles in the rabbit model.
    Wolska E; Sznitowska M; Chorążewicz J; Szerkus O; Radwańska A; Markuszewski MJ; Kaliszan R; Raczyńska K
    Eur J Pharm Sci; 2018 Aug; 121():95-105. PubMed ID: 29777856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.
    Parrilha LR; Nai GA; Giuffrida R; Barbero RC; Padovani LD; Pereira RH; Silva DA; Silva MC; Diniz MS; Andrade SF
    Arq Bras Oftalmol; 2015; 78(5):295-9. PubMed ID: 26466228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cyclosporine eye drops: A 4-year retrospective study (2009-2013)].
    Kauss Hornecker M; Charles Weber S; Brandely Piat ML; Darrodes M; Jomaa K; Chast F
    J Fr Ophtalmol; 2015 Oct; 38(8):700-8. PubMed ID: 26371985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen as a delivery system for hydrophobic drugs: studies with cyclosporine.
    Gebhardt BM; Kaufman HE
    J Ocul Pharmacol Ther; 1995; 11(3):319-27. PubMed ID: 8590264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers.
    Di Tommaso C; Torriglia A; Furrer P; Behar-Cohen F; Gurny R; Möller M
    Int J Pharm; 2011 Sep; 416(2):515-24. PubMed ID: 21219997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea.
    Yenice I; Mocan MC; Palaska E; Bochot A; Bilensoy E; Vural I; Irkeç M; Hincal AA
    Exp Eye Res; 2008 Sep; 87(3):162-7. PubMed ID: 18675411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclosporine A formulations on bovine corneal absorption: ex-vivo study.
    Le Bourlais CA; Chevanne F; Turlin B; Acar L; Zia H; Sado PA; Needham TE; Leverge R
    J Microencapsul; 1997; 14(4):457-67. PubMed ID: 9229345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of cyclosporine treatments for treatment of ocular surface diseases.
    Flts A; Medina R; Akpek EK
    Curr Opin Allergy Clin Immunol; 2024 Oct; 24(5):360-367. PubMed ID: 39079156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of cyclosporin A into the rabbit cornea and aqueous humor after topical drop and collagen shield administration.
    Kanpolat A; Batioglu F; Yilmaz M; Akbas F
    CLAO J; 1994 Apr; 20(2):119-22. PubMed ID: 8044977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison between local and systemic administration of cyclosporin A on the effective level in conjunctiva, aqueous humor and serum].
    Pfau B; Kruse FE; Rohrschneider K; Zorn M; Fiehn W; Burk RO; Völcker HE
    Ophthalmologe; 1995 Dec; 92(6):833-9. PubMed ID: 8563433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semifluorinated alkanes as a liquid drug carrier system for topical ocular drug delivery.
    Dutescu RM; Panfil C; Merkel OM; Schrage N
    Eur J Pharm Biopharm; 2014 Sep; 88(1):123-8. PubMed ID: 24844949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection.
    Gebhardt BM; Varnell ED; Kaufman HE
    J Ocul Pharmacol Ther; 1995; 11(4):509-17. PubMed ID: 8574814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety evaluation of nanoliposomes containing cyclosporine a after ocular administration.
    Mosallaei N; Banaee T; Farzadnia M; Abedini E; Ashraf H; Malaekeh-Nikouei B
    Curr Eye Res; 2012 Jun; 37(6):453-6. PubMed ID: 22577761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection.
    Li Q; Li Z; Zeng W; Ge S; Lu H; Wu C; Ge L; Liang D; Xu Y
    Eur J Pharm Sci; 2014 Oct; 62():115-23. PubMed ID: 24905830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo distribution and ex vivo permeation of cyclosporine A prodrug aqueous formulations for ocular application.
    Rodriguez-Aller M; Guillarme D; El Sanharawi M; Behar-Cohen F; Veuthey JL; Gurny R
    J Control Release; 2013 Aug; 170(1):153-9. PubMed ID: 23648835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.